Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

On Thursday, genetics-led consumer healthcare company 23andMe Holding Co. (NASDAQ:ME) announced a business restructuring to ...

NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...

23andMe, a popular South San Francisco-based genetic testing company, is laying off 40% of its workers after struggling with ...

23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s ...

Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...

In the wake of a big data breach and a sizable new round of layoffs, concerns about the 23andMe's handling of sensitive ...